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Abstract Five different splice variants of mouse ~36 subunit 
isoforms (cz2a-e), which arose from various combinations of 
three alternatively spliced regions, were cloned with a combina- 
tion of cDNA library screening and RT-PCR. Expression 
patterns and relative abundance of the various isoforms in mouse 
tissues were determined with an RNAse protection assay. 
Skeletal muscle and brain expressed single isoforms, cx2a and 
a2b, respectively; however, the cardiovascular system expressed 
all five isoforms. Heart expressed mainly isoforms u2c and tx2d 
while, in contrast to other species, aorta expressed predominantly 
&a, the ‘skeletal muscle’ isoform. Smooth muscle-containing 
tissues expressed a2d and a2e. Thus, a216 isoforms are 
restricted in their tissue expression, suggesting an important 
functional role for the differentially spliced variants. 
Key words: Calcium channel; Tissue-specific expression; 
Alternative splicing; RNAse protection assay 
1. Introduction 
Voltage-gated calcium channels have been purified from 
skeletal muscle, heart, and brain and consist of various com- 
binations of al, a2/6, B, and y subunits [l-3]. Molecular clon- 
ing studies have revealed the presence of multiple gene fam- 
ilies encoding the various subunits (for review, see [4]). To 
date six genes encoding al subunits have been cloned, and 
this protein accounts for not only the ion channel pore but 
also contains determinants for binding of various drugs and 
toxins [5]. Beta subunits, which are important for proper as- 
sembly, membrane targeting, and modulation of calcium 
channel gating properties, are encoded by four different genes 
[4,6]. At present, a single y subunit gene has been described 
and the encoded protein has only been found in skeletal mus- 
cle calcium channels [7]. 
The a2/6 subunit is a heavily glycosylated protein derived 
from proteolytic cleavage of a single gene product [8,9]. The 
a2 and 6 subunits are linked by disulfide bonds, and it was 
recently shown that the 6 subunit anchors the protein to the 
membrane via a single transmembrane domain and only five 
amino acids are intracellular [ 10,111. Functional co-expression 
of various al and p subunit cDNAs with a216 subunit cDNA 
has revealed a role for this subunit in modulation of current 
amplitude and also possibly activation/deactivation kinetics 
[ 122151. The mechanisms responsible are not known, although 
it has been speculated that a2/6 subunits may stabilize incor- 
poration of channel complexes in the membrane. Another 
functional role for the a2/6 subunit may be in regulating or 
mediating drug/toxin effects on voltage-gated calcium chan- 
*Corresponding author. Fax: (49) 89-3849-3261. 
E-mail: professor@ipt.mri.tu-muenchen.de 
nels. It has been shown that co-expression of a216 with the 
N-type calcium channel alB subunit, can increase the binding 
affinity for o-conotoxin [16]. Also, it has been demonstrated 
that the a216 subunit contains a high-affinity binding site for 
the new anticonvulsant drug gabapentin, although no effect 
on calcium channel function has been seen [ 17,181. Recent 
data suggested that a2/6 may also be important in regulating 
depolarization-induced neurosecretion in PC12 cells [19] and 
may be genetically linked to a subset of patients with malig- 
nant hyperthermia [20]. 
Although only one gene for a2/6 has been identified, cDNA 
cloning and PCR analysis has revealed different splice variants 
expressed in various species and tissues [16,21-231. To further 
understand the role of the a2/6 subunit in calcium channel 
physiology, pharmacology, and development, we first exam- 
ined this protein in the well-characterized model, the mouse. 
We initially cloned the different splice variants, investigated 
their tissue-specific expression, and then also determined their 
relative abundance in these various tissues. By using a combi- 
nation of library screening, PCR cloning, and RNAse protec- 
tion assays, we determined that like rat and human a2/6, 
single splice variants were found in mouse brain and skeletal 
muscle. However, it was discovered that the mouse cardiovas- 
cular system expressed all five splice variants, including the 
‘skeletal muscle’ a2a subunit. In addition, it was determined 
that the a2d and a2e subunits most likely constitute a variant 
of the a2/6 subunit predominant in tissues containing smooth 
muscle. 
2. Materials and methods 
Sequenase 2.0 and Thermosequenase were purchased from Amer- 
sham (UK). [32P]UTP (800 Ci/mmol) was purchased from ICN Bio- 
medical (UK). Restriction and modifying enzymes were purchased 
from either New England Biolabs (Germany) or Boehringer Mann- 
heim (Germany). 
2.1. Cloning and construction of a full-length cDNA 
A mouse brain cDNA library (Uni-ZAP XR, Stratagene) was 
screened with a 684 bp PCR-generated probe, derived from the rabbit 
skeletal muscle a2/6 sequence (bp 103-787) [21], that had been radio- 
labeled by random priming [24]. Six unique clones obtained from 
library screening were subcloned into pBlueScript II SK to create 
plasmids pa2.1-2.4, 2.6, and 2.8. Subcloning was carried out with 
the lambda-ZAP procedure outlined by the manufacturer. Inserts 
and derivative subcloned fragments were sequenced manually using 
a Sequenase 2.0 kit and T3, T7, or sequence-specific primers or with 
an ALF automated sequencer (Pharmacia) and a Thermosequenase 
kit. A full-length cDNA encoding the a2e splice variant was con- 
structed by subcloning an EcoRIIEcoRV fragment of pa2.4 (bp I- 
1718) into similarly digested pa2.8 (bp 1719-3882). The integrity of 
the cloning junction was verified by manual sequencing. Protein se- 
quence comparisons were done with the MULTALIGN program 
from the Heidelberg UNIX Sequence Analysis Resources (Heidel- 
berg). 
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2.2. Total and poly(A) RNA isolation 
Total RNA was obtained from 2-6-month-old male and female 
mice. RNA was isolated from aorta, brain, small intestine, heart, liver, 
lung, and skeletal muscle with a single step isolation procedure [25]. 
Poly(A) RNA was purified using a PolyATract III kit (Promega), 
according to the manufacturer’s instructions. 
2.3. Northern blot analysis 
Poly(A) RNA samples (14 pg each) along with a RNA molecular 
weight ladder (Gibco) were fractionated through a gel of 1% agarose/ 
6% formaldehyde/40 mM MOPS (pH 7.0) and then transferred to 
Hybond N (Amersham) using standard procedures [24]. The filter 
was prehybridized under stringent conditions at 60°C for 6 h in hy- 
bridization solution (5% SDS, 400 mM NaP04, 1 mM EDTA, 1 mg/ 
mg BSA, 50% formamide). To generate an antisense riboprobe, a 549 
bp ClnI-XbaI fragment of pa2.8 (bp 2940-3489) was subcloned in 
pBluescript KS II to create pa2.8D. Following digestion with 
Asp718, a labeled probe was synthesized with T7 RNA polymerase 
and [32P]UTP using a MAXIScript kit (Ambion). Filter and probe 
(5.0x lo6 cpm/ml) were hybridized overnight in the above solution 
and then washed stringently at 70°C for 2 h in 0.1 X SSC/O.l% SDS/ 
1.0 mM EDTA, prior to exposure to Hyperfilm (Amersham). 
2.4. RT-PCR amplification of splice variants 
Approximately 1.0 ug of poly(A) RNA from various tissues was 
converted to single-stranded cDNA by priming with an oligo-dT 
primer, followed by a 20 ul reverse transcription reaction with 200 
U of Superscript II (Gibco), and digestion with 3 U of RNAse H 
(G&co) [24]. For RT-PCR amplification, 1.0 pl of cDNA was mixed 
with primers MA2RPA5 (5’-GGCCGGATCCGCAATTGATC- 
CTAATGGC-3’, bp 1770-1787) and MAZSEQI (5’-GCACACG- 
GATCCCTGATTGAAGTT-3’, bp 26542677) and amplified wa 
2.5 U Pfu polymerase (Stratagene) for 35 cycles. PCR products 
were digested with BamHI (sites underlined in primers above), elec- 
trophoresed, eluted, and cloned into BamHI digested pBluescript KS 
II (Stratagene). Individual clones were manually sequenced as above 
with T3, T7, and sequence specific primers. 
2.5. RNAse protection assays 
An antisense riboprobe containing both alternatively spliced regions 
was constructed for use in RNAse protection assays (RPA) (see Fig. 
4). RT-PCR amplification of a 462 bp fragment of a2a (skeletal mus- 
cle cDNA) and 426 bp fragment of ct2b (brain cDNA) was performed 
using primers that flanked the alternatively spliced regions: MA2R- 
PA5 (see above) and MA2RPA3 (S’-GCGCGGTACCGCAG- 
TATTCCCTTGGTG-3’, bp 2157-2174). The fragments were digested 
with BamHI and Asp718 (site underlined in primer above), subcloned 
into similarly digested pBluescript II KS, to form plasmids pMA2a 
and pMA2b, respectively. In addition, a similar 405 bp fragment was 
amplified from pct2.8 (lacking both alternatively spliced regions A and 
C) and subcloned to form plasmid pMA2e. To construct the final 
RPA probe, pMA2a and pMA2b were cut with StyI, and a 128 bp 
fragment from pMA2b (bp 203332160, containing alternatively 
spliced region C) was subcloned into pMA2a (containing alternatively 
spliced regions A and B) to form the plasmid pMA2RPA2. All plas- 
mids were sequenced to confirm their identities. Radiolabeled anti- 
sense riboprobe was synthesized from BamHI linearized pMA2RPA2 
with T3 RNA polymerase and [32P]UTP using a MAXIScript kit. 
RNAse protection assays of total RNA isolated from various tissues 
or positive control sense RNAs were performed using an RPA II kit 
(Ambion) according to the manufacturer’s instructions, with the fol- 
lowing modifications: 1 X 10” cpm of probe (200 pg RNA) was added 
per assay, RNAse Tl was used at a final dilution of 1 : 100, and 
digestions were allowed to proceed for 12 h at 37°C to ensure com- 
plete digestion of probe. Samples were analyzed by 5% PAGE/8 M 
urea gel, followed by drying of the gel and exposure to Hypefilm or a 
FUJIFILM BAS 1500 Imaging System. A radiolabeled RNA molec- 
ular weight ladder was synthesized using T3 RNA polymerase and 
various other templates of known sizes. Sense RNA controls were 
synthesized from Asp718 linearized pMA2a, pMA2b, and pMA2e 
using T7 RNA polymerase in the presence of unlabeled deoxynucleo- 
tides, quantified on a spectrophotometer, and diluted to a final work- 
ing concentration of 10 pg/pl. 
2.6. Miscellaneous 
The nucleotide sequences of mouse a2a, a2b, a2c, a2d and a2e 
have been submitted to Genbank and can be found under accession 
numbers U73483, U73484, U73485, U73486, and U73487, respec- 
tively. 
3. Results 
3.1. cDNA sequence of mouse 05% subunit 
Screening of more than 1 X lo6 recombinants from a mouse 
brain cDNA library yielded four overlapping clones, a2.1- 
1~2.4, which extended from the 5’untranslated region to the 
middle of the open reading frame. Clone a2.1 was used to 
rescreen the library and two more unique clones were isolated, 
a2.6 and 1~2.8, which encoded the remaining carboxy terminus 
of the protein and the poly(A) tail. Together, clones a2.4 and 
1~2.8 had an approximately 1300 bp overlap (bp 812-2104) 
and represented a full-length cDNA clone with their com- 
bined sequence encoding a contiguous open reading frame 
of 3252 bp (1084 amino acids). The complete cDNA sequence 
had a total of 3882 bp, with 230 bp of 5’ UTR and 400 bp of 
3’ UTR including the poly(A) tail (data not shown). All 
clones were sequenced in their entirety and no cloning discrep- 
ancies were discovered between the various clones, except for 
splicing variations (see below). 
When compared to other known forms of a2/6 from differ- 
ent species, the encoded protein was found to have 98.4%, 
95.9%, and 95.4% amino acid homology with rat, human, 
and rabbit homologs, respectively. Most differences consisted 
of conservative amino acid changes (Fig. 1). A comparison of 
the deduced protein sequences from these four species re- 
vealed several areas of distinctions. The most notable differ- 
ence was the absence of the alternatively spliced regions iden- 
tified previously in 01216 subunits from skeletal muscle and 
brain [21,23]. The 19 amino acid insertion seen in skeletal 
muscle would be found between amino acids 506 and 507 of 
the mouse a2/6 sequence, whereas the seven amino acid inser- 
tion seen in brain would be found between amino acids 601 
and 602. Previously, an isoform of a216 subunit lacking these 
regions was been given the nomenclature a2e, whereas the 
isoforms cloned from skeletal muscle and brain were given 
the nomenclature a2a and a2b, respectively [16,22]. The a2e 
isoform of a216 had been previously obtained by RT-PCR 
amplification. However, a cDNA encoding this alternatively 
spliced region of the protein was found completely within 
clone a2.8 obtained from our library screening, thus this com- 
bination of alternate splicing/exon usage was found in a con- 
tiguous sequence. 
Based on the known amino terminal sequence of the 6 
subunit [8], this subunit would arise from putative cleavage 
between ‘14A and ‘15V (Fig. 1). Though the 6 subunit is iden- 
tical between mouse and rat, except for the last amino acid, 
more divergence was seen within this subunit among mouse, 
human and rabbit sequences. This divergence was most con- 
centrated within the extreme carboxy terminal 20 amino acids 
that form the transmembrane domain responsible for mem- 
brane anchoring of the a2/6 subunit [lo]. 
3.2. Tissue distribution of &?I6 subunit 
Tissue expression of the a216 subunit was determined by 
Northern blot hybridization. After probing with a riboprobe 
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Fig. 1. Amino acid alignment of a2/6 subunits. Mouse ct2e isoform was aligned with rat a2b (Genbank M86621), human a2b (Genbank 
L12887), and rabbit a2a (Genbank M21948) sequences using the MULTALIGN program from HUSAR. Introduced gaps are signified by a 
period (.) and identical amino acids are indicated with a dashed line (-). The signal peptide is shown in bold and amino acid numbering of 
the mature polypeptide starts with +l. The proposed site of cleavage which separates the a2 and 6 subunits is underlined (g14A_g15V). 
complimentary to the 3’ coding region, a predominant full- 
length message of 8.5 kb was seen in brain, heart, and skeletal 
muscle. No message was observed in liver (Fig. 2). In addi- 
tion, overexposure of the blot showed similarly sized messages 
in aorta, small intestine, and lung (data not shown). The weak 
signal in aorta most likely resulted from the smaller quantity 
1234567 
-8.5 
2.4 --) 
1.4 --) 
Fig. 2. Northern blot analysis. Various amounts of poly(A) RNA 
were analyzed after electrophoresis through a formaldehyde agarose 
gel as described in Section 2. Lanes (1) aorta; (2) brain; (3) small 
intestine; (4) heart; (5) liver; (6) lung; (7) skeletal muscle. One mi- 
crogram (aorta, skeletal muscle) or 4 ug (all other tissues) were ana- 
lyzed. RNA molecular weight standards are indicated on left. The 
blot was exposed to Hyperfilm for 18 h. Overexposure revealed spe- 
cific 8.5 kb bands in lanes 1, 3, and 6 (data not shown). 
of poly(A) RNA loaded (1 pg), which was necessitated by the 
lower amounts of RNA isolated from this small tissue, 
whereas the weak signal in other tissues most likely reflected 
their relative abundance. Despite the weak signals ins some 
tissues, the relative abundance of a2/6 mRNA is consistent 
with that seen by RNAse protection assay (see below). 
3.3. Cloning of other alternatively spliced ct.216 isoforms 
A full-length cDNA encoding the a2e isoform was con- 
structed by combining clones ~~2.4 and a2.8 (see Section 2). 
However, the previously identified brain isoform, a2b, could 
not be constructed with the clones isolated from the cDNA 
library screening, because no clones were obtained that con- 
tained the complete alternatively spliced region C (see Section 
4). Therefore we utilized a RT-PCR cloning strategy to isolate 
this isoform and to also determine if other isoforms of a2/6 
that were not isolated by library screening were expressed in 
mouse tissues. RT-PCR analysis of poly(A) RNA isolated 
from mouse aorta, brain, heart, small intestine, lung, and 
skeletal muscle was performed. Initial polyacrylamide gel 
analysis of the RT-PCR products showed the presence of 
single PCR products in brain and skeletal muscle, but multi- 
ple products in other tissues examined (data not shown). 
PCR products from brain, skeletal muscle, and heart tissue 
were then subcloned and sequenced. cDNA and deduced ami- 
no acid sequences for the various isoforms amplified were 
compared. Together, four different isoforms of a2/6 (a2ad) 
were seen in these tissues, not including the original a2e iso- 
form. These five isoforms were generated by alternative splic- 
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A 
A B C 
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a2a ..500HpNLQpKPIGVGIPTINLRKRRPNVQ~QEPVTLDFLD53g...610KLEETITQARY...... .SETLKPD6".. 
a2b ..500HPNLQPK...................NPKSQEPVTLDFLD520.. .5g1KLEETITQARSKKGKMKDSETLKPD615.. 
a2c . . 5ooHPNLQPK........................EPVTLDFLD515.. .5*6KLEETITQARSKKGKMKDSETLKPD610.. 
a2d . . 5ooHPNLQPK........................EPVTLDFLD515...5*6KLEETITQARY.......SETLKPD603.. 
a2e . . 5ooHPNLQPK...................NPKSQEPVTLDFLD520...5g1KLEETITQARY.......SETLKPD"oB.. 
B ..CCA AAG CCT ATT GGT GTA GGT ATA CCG ACA ATT AAT TTA AGG 
PKPIGVGIPTINLR 
AAA AGG AGA CCC AAC GTT CAG AAC CCC AAA TCT CAG GAG CCA.. 
K R R P N V FNP K STEP 
C aZa/d/e ..CAG GCC AGA TAT TCA GAA ACC.. 
Q A R Y S E T 
a2b/c ..CAG GCC AGA TCA AU AAG GGA AhA ATG AAG GAT TCA GAA ACC 
QARSKKGKMKDSET 
Fig. 3. Comparison of mouse ct2/6 splice isoforms. A: Amino acid comparison of five splice variants obtained from RT-PCR and library 
screening. Alternatively spliced regions (A, B, and C) are indicated above isoform a2a. B: cDNA sequence and encoded amino acids of regions 
A and B. Alternate splice acceptor sites (CAG) are underlined. C: cDNA sequence and encoded amino acids of region C. Alternatively spliced 
sequences and encoded amino acids are indicated in bold face type. 
ing of three different regions (A, B, and C) between sooH and 
608D of a2e (Fig. 3A). Initial analysis of the subcloned RT- 
PCR fragments showed that skeletal muscle and brain ex- 
pressed only single isoforms of a2/6, a2a and a2b, respec- 
tively, whereas heart was found to express a2c and a2d in 
approximately a 9 : 1 ratio respectively (data not shown). Se- 
quencing of several clones from RT-PCR amplification of 
brain, heart, and skeletal muscle did not reveal the a2e iso- 
form, suggesting it may be a rare message (data not shown). 
As seen previously, skeletal muscle expressed an isoform 
that contained a 19 amino acid insertion (region A), encoded 
by a 57 bp sequence (Fig. 3B). The next alternatively spliced 
region B was found adjacent to the carboxy terminal end of 
region A and encoded the five amino acid sequence NPKSQ. 
Based on the cDNA sequences surrounding regions A and B, 
it appeared that alternate usage of splice acceptor sites (trinu- 
cleotide CAG encoding 525E and 530E, of a2a) accounted for 
the differential splicing seen. Supporting this possibility is the 
presence of pyrimidine-rich regions immediately 5’ to the al- 
ternate splice acceptor sites mentioned above, which are know 
to be important determinants of mRNA splicing junctions 
WI. 
Isoforms a2b and a2c differ from the other isoforms by the 
presence of region C, the last alternatively spliced site (Fig. 
3C). No consensus splice donor or acceptor sequences are 
present in this 21 bp region, suggesting that it is encoded by 
a single exon [26]. Alternate splicing of this exon inserts seven 
amino acids into the protein and in addition, converts an 
eighth amino acid 601Y to 601S (based on a2b). 
3.4. Relative distribution of a2/6 isoforms in various tissues 
We next wanted to determine the distribution and relative 
abundance of the various isoforms in different tissues known 
to express the a216 subunit. Though RT-PCR can demon- 
strate the presence or absence of a particular message, it is 
only quantitative when done under appropriate conditions 
[24]. In contrast, Northern blot hybridization can show rela- 
tive abundance of a message across various tissues (see 
above). However, the limitation of the latter technique is 
that it cannot show the relative abundance of a given isofonn 
Fig. 4. RNAse protection assay (RPA) of a2/6 isoform expression. A: Schematic of probe used for RPA, showing alternatively spliced regions 
A, B, and C, followed by expected fragments ( > 200 bp) generated by RPA of each isoform. Size of probe or expected fragment is shown to 
right. B: RPA of total RNA from various tissues. Lanes (1) Probe (- RNAse); (2) Probe (+ RNAse); (3) a2b sense RNA; (4) a2a sense 
RNA; (5) a2e sense RNA; (6) 40 ug aorta; (7) 20 ug brain; (8) 20 ug heart; (9) 10 ug skeletal muscle RNA. Dried gel was exposed to Hyper- 
film for 3 days. C: RPA of total RNA from small intestine and lung. Lanes (1) 50 ug small intestine; (2) 10 ug heart; (3) 50 ug lung RNA. 
Dried gel was exposed to Fuji imaging plate for 3 days. RNA molecular weight markers are indicated to left; identification of fragments are in- 
dicated between B and C. Full-length probe and protected fragments generated from sense RNA (B, lanes 3-5) are slightly larger than cDNA 
counterparts due to presence of complimentary vector sequences. 
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of a message within a tissue unless multiple blots are probed 
with isoform-specific probes. Thus, to more easily determine 
which a216 isoforms were expressed in which tissues and to 
determine their relative amounts, an RNAse protection assay 
(RPA) was utilized. To enhance the ability of the RPA to 
discriminate between the different isoforms, a probe template 
which contained all three alternatively spliced regions A, B, 
and C was created by subcloning various RT-PCR products. 
A schematic showing the constructed probe and the expected 
fragments generated by RPA is shown (Fig. 4A). Total RNA 
from various tissues was hybridized to [32P]UTP labeled anti- 
sense riboprobe and digested with RNAse Tl. As a positive 
control, in vitro transcribed sense RNAs for a2a, a2b, and 
a2e isoforms were also analyzed (Fig. 4B). The positive con- 
trol RNAs gave protected fragments of the correct size. The 
identity of various fragments were confirmed by comparing 
the relative migration of each band to that of known molec- 
ular weight standards (data not shown). As expected from 
RT-PCR analysis, skeletal muscle expressed only a single iso- 
form, a2a and brain expressed exclusively the a2b isoform. 
The original isoform cloned from the brain library, a2e, was 
not detectable in brain. The limit of detection as determined 
with sense control RNAs was 1 pg (data not shown). The two 
isoforms of a2/6 amplified from heart, a2c and a2d, were 
found in this tissue, with a2c being the most abundant. How- 
ever, heart also expressed significant amounts of a2b and also 
a small amount of a2e. Most interesting was the discovery 
that the predominant isoform in aorta was not the previously 
identified isoforms seen in other species (a2d or a2e), but 
isoform a2a. This observation was repeated with a second 
RNA preparation from aorta and a similar result was seen 
on RT-PCR analysis of aorta poly(A) RNA (data not shown). 
RPA examination of a2/6 expression in small intestine and 
lung revealed that the predominant isoforms were a2d, with a 
small amount of a2e also being seen (Fig. 4C). No protected 
fragment of 484 bp, representing a possible sixth isoform con- 
taining all three alternatively spliced region A, B, and C was 
seen in any tissues tested. 
4. Discussion 
A combination of library screening and RT-PCR revealed 
the existence of five isoforms of the mouse a2/6 subunit, aris- 
ing from alternate splicing of three regions (A, B, C) of the 
mRNA. Splicing of the a2/6 subunit in mouse tissues appears 
to be similar to other species examined [16,21,23]. Usage of 
alternate splice acceptor sites in regions A and B and the 
presence of an alternatively spliced exon, region C, would 
account for the five different isoforms. All possible combina- 
tions of the three alternatively spliced regions A, B, and C 
were discovered, except one (region B cannot be spliced out 
without removal of region A). This excluded combination 
would be a subunit that contained all three regions. However, 
it was not seen by RT-PCR, sequencing, nor RPA of various 
mouse tissues and has not been described in other species. 
Therefore, it may exist in other tissues not tested or at ex- 
tremely low levels. 
Only two clones from the original mouse brain library 
screen extended over the alternatively spliced regions. Clone 
a2.8 was missing regions A and C thus classifying it as the 
a2e isoform. The other clone, a2.4, extended into the alter- 
natively spliced region, but it was an aberrant clone that in- 
itiated from within region C due to false priming of the library 
(data not shown). However, this clone also lacked region A, 
thus a full-length clone would have been given the nomen- 
clature of a2b. Therefore, two forms of a2/6 subunit were 
isolated from this brain library, a2b and a2e. However, the 
a2b and not the a2e isoform was expressed in mouse brain, as 
assessed by RPA, thus suggesting that the presence of the 
latter isoform in the cDNA library came from another tissue 
source, possibly vascular smooth muscle (see below). 
Isoforms of a216 subunit have been identified previously by 
PCR analysis of rabbit, rat, and human tissues and cell lines 
[16,21,23,27]; however, only partial information about the a21 
6 subunit from mouse cochlea was reported previously [28]. It 
had been speculated that these splice variants arose from tis- 
sue-specific splicing events, as the a2a isoform was only iden- 
tified in skeletal muscle and a2b was only found in CNS 
tissues or derivative cell lines. However, our RPA analysis 
of various mouse tissues has revealed that the previously 
termed skeletal muscle isoform, a2a, is the predominant var- 
iant in aorta, and the brain specific isoform, a2b, is expressed 
to significant levels in heart. Initial RT-PCR studies by Green 
et al. [28], suggested that a2b may be expressed in mouse 
lung, however, that was based on PCR product size alone 
and was not confirmed by sequencing. The results of our 
RPA analysis suggested that this isoform was not the predom- 
inant form in mouse lung. 
Previous Northern blot analysis of rabbit aorta, ileum, and 
lung revealed the presence of an a2/6 transcript, similar to our 
results with mouse tissues, though the exact isoform(s) ex- 
pressed in these tissues was not determined [21,29]. Previous 
RT-PCR analysis of human aorta has revealed the presence of 
a2c, a2d, and a2e isofonns, but the relative abundance of 
these different isoforms was not mentioned [16]. A more quan- 
titative RPA analysis of the tissues from mouse revealed that 
a2d was the most abundant isoform in small intestine and 
lung, with a lower expression level of a2e. A similar ratio 
of a2d to a2e was seen in mouse aorta and heart, though 
these were not the most abundant isoforms in these. tissues. 
The finding of a2d and a2e isoforms in small intestine, aorta, 
and lung, tissues known to express the alC subunit [4], sug- 
gests that these two isoforms may co-assemble to form cal- 
cium channels in vasculature and other tissues which contain 
smooth muscle. This result may explain the original cloning of 
the a2e isoform from a brain library, an organ known to have 
extensive vasculature. However, a2e was also amplified from 
HEK 293 and PC12 cells [ 16,271 and sequencing of an a2/6 
fragment amplified from mouse cochlea suggested the pres- 
ence of a2d, proving again that the different isoforms are 
not tissue specific. 
The presence of all five isoforms in the mouse cardiovascu- 
lar system (aorta and heart) suggests that the different splice 
variants may have specific, but yet unknown, functions. 
Mouse heart expressed predominantly a2c and a2d and was 
the only tissue tested that expressed the former isoform. No 
obvious functional domains could be identified in the three 
alternatively spliced regions to give insight into possible func- 
tions. Heart is not a homogeneous tissue and consists of con- 
tractile and specialized conducting tissues and also expresses 
both L- and T-type calcium channel currents [4,30]. Thus it 
would be of interest to use in situ hybridization or other 
techniques to determine the exact cellular location of these 
different isoforms. 
T Angelotti, I? HqfmannIFEBS Letters 397 (1996) 331-337 
By using a highly specific and sensitive RPA analysis, we 
were able to determine the relative level of expression of a216 
subunit mRNA between various mouse tissues and also de- 
termine the relative abundance of any given isoform within a 
tissue. Our results demonstrate that the multiple splice var- 
iants of the a2/6 subunit have been conserved between mice 
and humans, though they differ with respect to tissue expres- 
sion, suggesting a functional role for these different isoforms. 
Recent evidence that a216 can modulate calcium channel cur- 
rents, w-conotoxin binding, neurosecretion, and form a high- 
affinity binding site for the anticonvulsant gabapentin implies 
that the various isoforms may differ with respect to these 
effects [13,16,17,19,20]. Future experiments will need to be 
directed at examining these possibilities and these will be 
aided by having cloned the full-length cDNAs encoding all 
five mouse a2/6 subunit isoforms. 
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